20. Loss Per Share The computation of loss per share is as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2026 |
|
|
2025 |
|
(in thousands, except share and per share amounts) |
|
|
|
Numerator: |
|
|
|
|
|
|
Net loss |
|
$ |
(10,743 |
) |
|
$ |
(6,603 |
) |
Net loss attributable to common stockholders |
|
$ |
(10,743 |
) |
|
$ |
(6,603 |
) |
Denominator: |
|
|
|
|
|
|
Weighted average common stock outstanding -
basic and diluted |
|
|
1,049,454 |
|
|
|
38,041 |
|
Net loss per share attributable to common
stockholders - basic and diluted |
|
$ |
(10.24 |
) |
|
$ |
(173.58 |
) |
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
2026 |
|
|
2025 |
|
Warrants to purchase common stock |
|
|
268,546 |
|
|
|
75,821 |
|
Series A Convertible Preferred Stock conversion to common stock |
|
|
229,338 |
|
|
|
29,847 |
|
Series B Convertible Preferred Stock conversion to common stock |
|
|
2 |
|
|
|
3 |
|
Series C Convertible Preferred Stock conversion to common stock |
|
|
16,143 |
|
|
|
11,515 |
|
Notes payable conversion to common stock |
|
|
387,914 |
|
|
|
44,371 |
|
Stock options to purchase common stock |
|
|
7 |
|
|
|
8 |
|
Total |
|
|
901,950 |
|
|
|
161,565 |
|
The Company's Series D Convertible Preferred Stock and Series E Convertible Preferred Stock are also potentially convertible into Common Stock, however the conversion price is unknown as of March 31, 2026. |